Login / Signup

Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification.

Siqing FuShuyang YaoYuan YuanRebecca Ann PrevisAnthony D EliasRichard D CarvajalThomas J GeorgeYing YuanLihou YuShannon Neville WestinYan XingEcaterina E Ileana DumbravaDaniel D KarpSarina A Piha-PaulApostolia-Maria TsimberidouJordi Rodon AhnertNaoko TakebeKaren H LuKhandan KeyomarsiFunda Meric-Bernstam
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
-amplified epithelial ovarian cancer is warranted.
Keyphrases
  • nucleic acid
  • open label
  • double blind
  • cross sectional
  • placebo controlled
  • label free